# Ultra-early Identification of Futile Recanalization After Reperfusion Therapy in Acute Ischemic Stroke Based on Cerebral Autoregulation Monitoring

Study · id `cardio:ct-nct07747701` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07747701](<https://clinicaltrials.gov/study/NCT07747701>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07747701

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 227 participants.

## Technical summary

Registry record NCT07747701. Allocation not applicable; no masking; primary purpose diagnostic. Start 2026-07-31 (actual); primary completion 2027-01-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 227 participants (planned count; ClinicalTrials.gov record NCT07747701, source copy `cardio:ctgov-nct07747701-2026-11-09`, retrieved 2026-11-18)
- Started: 2026-07-31 (actual) (ClinicalTrials.gov record NCT07747701, source copy `cardio:ctgov-nct07747701-2026-11-09`, retrieved 2026-11-18)
- Primary completion: 2027-01-31 (anticipated) (ClinicalTrials.gov record NCT07747701, source copy `cardio:ctgov-nct07747701-2026-11-09`, retrieved 2026-11-18)
- Completion: 2027-02-05 (anticipated) (ClinicalTrials.gov record NCT07747701, source copy `cardio:ctgov-nct07747701-2026-11-09`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT07747701, source copy `cardio:ctgov-nct07747701-2026-11-09`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07747701-2026-11-09`, retrieved 2026-11-18)

## The registry's words

- Brief title: Ultra-early Identification of Futile Recanalization After Reperfusion Therapy in Acute Ischemic Stroke Based on Cerebral Autoregulation Monitoring
- Acronym: FACTOR
- Condition: Acute Ischemic Stroke
- Condition: Cerebral Autoregulation
- Intervention (Device): NIRS-based cerebral oxygenation and blood pressure monitoring
- Intervention (Procedure): Carotid compression test
- Lead sponsor: Beijing Shijitan Hospital, Capital Medical University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Beijing Shijitan Hospital, Capital Medical University (`cardio:org-beijing-shijitan-hospital-capital-medical-university`)

## Provenance

Content hash: a3b0407a7e39b3fcf9c94911f591cac0a2edba61c9a34c4e44125eb9a51116be
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
